All Relations between alb and tp53

Publication Sentence Publish Date Extraction Date Species
Daermu Qumu, Mu Tian, Hengxi Li, Xiujuan Yang, Binhui Han, Lanting Wei, Bo Li, Mengxue Ma, Junjie He, Xiaoni Sha. Study on the Mechanism of Galangin on Hyperuricemic Nephropathy Based on Metabolomics and Network Pharmacology. Molecular nutrition & food research. 2025-03-28. PMID:40150835. network pharmacology and experimental results showed that gal reduced the key target expression of the tumor protein p53 (tp53), tumor necrosis factor (tnf), signal transducer and activator of transcription 3 (stat3), heat shock protein 90 alpha family class a member 1 (hsp90aa1), albumin (alb), and caspase-3 (casp3). 2025-03-28 2025-03-30 mouse
Xinyu Yan, Yiyi Zhang, Jingwen Mo, Lindong Xu, Keyu Shi, Yi Zho. Molecular docking and network pharmacology research on the Danggui Sini Decoction's mechanism of action for treating erectile dysfunction. Medicine. vol 103. issue 47. 2025-01-14. PMID:39809170. this study demonstrates that dgsnd's compounds stimulate no synthesis and reduce inflammation and cell apoptosis to improve ed by acting on akti, alb, il6, tnf, tp53, and bcl2. 2025-01-14 2025-01-17 Not clear
Jiangang Zheng, Abdul Haseeb, Ziyang Wang, Hejie Wan. Network pharmacology, computational biology integrated surface plasmon resonance technology reveals the mechanism of ellagic acid against rotavirus. Scientific reports. vol 14. issue 1. 2024-03-30. PMID:38555283. the results of network pharmacological analysis showed that there were 35 intersection proteins, among which interleukin-1β (il-1β), albumin (alb), nuclear factor kappa-b1 (nf-κb1), toll-like receptor 4 (tlr4), tumor necrosis factor alpha (tnf-α), tumor protein p53 (tp53), recombinant smad family member 3 (samd3), epidermal growth factor (egf) and interleukin-4 (il-4) were potential core targets of ea anti-rv. 2024-03-30 2024-04-02 Not clear